Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Levetiracetam as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy for Bridging Purpose With a Similar Study on Caucasian Epileptic Subjects

NCT00160628 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00160628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Levetiracetam as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy for Bridging Purpose With a Similar Study on Caucasian Epileptic Subjects
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
October 31, 2004
Enrollment
100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial